WNK2 and schizophrenia: At the same time, KEGG functional enrichment analysis was performed for the identified differential proteins, which revealed that the proteins with significant differences in their levels between the schizophrenia group and the control group are mainly enriched in the mitogen-activated protein kinase (MAPK) signaling pathway, which had been confirmed by Western blot studies on brain tissue (29).